Rachel Krupa

670 total citations
26 papers, 469 citations indexed

About

Rachel Krupa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Rachel Krupa has authored 26 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Rachel Krupa's work include Cancer Cells and Metastasis (17 papers), Prostate Cancer Treatment and Research (15 papers) and Cancer Genomics and Diagnostics (8 papers). Rachel Krupa is often cited by papers focused on Cancer Cells and Metastasis (17 papers), Prostate Cancer Treatment and Research (15 papers) and Cancer Genomics and Diagnostics (8 papers). Rachel Krupa collaborates with scholars based in United States, United Kingdom and Israel. Rachel Krupa's co-authors include Ryan Dittamore, Ryon P. Graf, Adam Jendrisak, Jessica Louw, Mark Landers, David Lu, Howard I. Scher, Nicole A. Schreiber, Lyndsey Dugan and Dena Marrinucci and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Rachel Krupa

25 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Krupa United States 8 320 266 250 108 44 26 469
Bin-Chao Wang China 9 386 1.2× 426 1.6× 172 0.7× 133 1.2× 31 0.7× 21 560
Maheshwari Ramineni United States 7 308 1.0× 123 0.5× 338 1.4× 70 0.6× 38 0.9× 16 539
Anne Renolen Norway 9 385 1.2× 98 0.4× 252 1.0× 110 1.0× 18 0.4× 13 468
Nicolas Kiavué France 10 257 0.8× 110 0.4× 179 0.7× 110 1.0× 16 0.4× 13 363
Robert Konschak Germany 9 241 0.8× 102 0.4× 189 0.8× 120 1.1× 18 0.4× 12 397
Antonio Russo Italy 8 296 0.9× 270 1.0× 155 0.6× 114 1.1× 36 0.8× 14 428
Elisabeth Trapp Germany 13 303 0.9× 97 0.4× 252 1.0× 133 1.2× 40 0.9× 25 417
Daisy Dandan Wang United States 12 407 1.3× 111 0.4× 298 1.2× 130 1.2× 52 1.2× 17 515
Lisa Flaum United States 11 370 1.2× 207 0.8× 299 1.2× 127 1.2× 81 1.8× 32 535
Risa Oshitanai Japan 8 331 1.0× 238 0.9× 78 0.3× 46 0.4× 76 1.7× 15 431

Countries citing papers authored by Rachel Krupa

Since Specialization
Citations

This map shows the geographic impact of Rachel Krupa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Krupa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Krupa more than expected).

Fields of papers citing papers by Rachel Krupa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Krupa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Krupa. The network helps show where Rachel Krupa may publish in the future.

Co-authorship network of co-authors of Rachel Krupa

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Krupa. A scholar is included among the top collaborators of Rachel Krupa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Krupa. Rachel Krupa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, David, Rachel Krupa, Melissa Harvey, et al.. (2020). Development of an immunofluorescent AR-V7 circulating tumor cell assay – A blood-based test for men with metastatic prostate cancer. SHILAP Revista de lepidopterología. 9(1). 13–19. 8 indexed citations
2.
Boffa, Daniel J., Ryon P. Graf, Michelle C. Salazar, et al.. (2017). Cellular Expression of PD-L1 in the Peripheral Blood of Lung Cancer Patients is Associated with Worse Survival. Cancer Epidemiology Biomarkers & Prevention. 26(7). 1139–1145. 61 indexed citations
3.
Scher, Howard I., Ryon P. Graf, Nicole A. Schreiber, et al.. (2017). Phenotypic Heterogeneity of Circulating Tumor Cells Informs Clinical Decisions between AR Signaling Inhibitors and Taxanes in Metastatic Prostate Cancer. Cancer Research. 77(20). 5687–5698. 94 indexed citations
4.
Krupa, Rachel, David Lu, Ryon P. Graf, et al.. (2016). Characterization of programmed cell death-1 ligand (PD-L1) expression in circulating tumor cells (CTCs) of lung cancer. Journal of Thoracic Oncology. 11(2). S52–S52. 1 indexed citations
5.
Anantharaman, Archana, Terence W. Friedlander, David Lu, et al.. (2016). Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) and white blood cells (WBCs) in muscle invasive and metastatic bladder cancer patients.. Journal of Clinical Oncology. 34(2_suppl). 446–446. 3 indexed citations
6.
7.
Anantharaman, Archana, Terence W. Friedlander, David Lu, et al.. (2016). Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients. BMC Cancer. 16(1). 744–744. 90 indexed citations
8.
Fujii, Takeo, James M. Reuben, Rachel Krupa, et al.. (2016). Abstract 496: Androgen receptor expression on circulating tumor cells in metastatic breast cancer. Cancer Research. 76(14_Supplement). 496–496. 1 indexed citations
9.
Anantharaman, Archana, Terence W. Friedlander, David Lu, et al.. (2016). Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.. Journal of Clinical Oncology. 34(15_suppl). 4527–4527. 9 indexed citations
10.
Boffa, Daniel J., Jorge J. Nieva, Lyudmila Bazhenova, et al.. (2016). Programmed cell death-1 ligand (PD-L1) expression on circulating CD45(-) cells is an independent prognostic factor for overall survival in patients (Pts) with lung cancer in a prospective, multicenter cohort.. Journal of Clinical Oncology. 34(15_suppl). 8524–8524. 1 indexed citations
11.
Beltran, Himisha, Adam Jendrisak, Mark Landers, et al.. (2015). The Initial Detection and Partial Characterization of Circulating Tumor Cells in Neuroendocrine Prostate Cancer. Clinical Cancer Research. 22(6). 1510–1519. 108 indexed citations
12.
13.
Lu, David, Ryon P. Graf, Melissa Harvey, et al.. (2015). Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells. PubMed. 4. 4–4. 8 indexed citations
14.
Lu, David, Richard Bambury, Dana E. Rathkopf, et al.. (2015). Abstract 1588: Single cell analysis of AR N terminal, AR C terminal and the ARv7 splice variant in the CTCs of metastatic castration resistant prostate cancer (mCRPC) patients. Cancer Research. 75(15_Supplement). 1588–1588. 4 indexed citations
15.
Dittamore, Ryan, Jessica Louw, Rachel Krupa, et al.. (2014). Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in progressive metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(4_suppl). 132–132. 5 indexed citations
16.
Autio, Karen A., Aseem Anand, Rachel Krupa, et al.. (2014). Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(4_suppl). 198–198. 3 indexed citations
17.
18.
Dittamore, Ryan, Jessica Louw, Rachel Krupa, et al.. (2014). Molecular characterization of circulating tumor cells (CTC) and CTC subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(15_suppl). e16018–e16018. 1 indexed citations
19.
Ferraldeschi, Roberta, Andrew S. McDaniel, Rachel Krupa, et al.. (2014). CK- and small nuclear size circulating tumor cell (CTCs) phenotypes in metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 32(4_suppl). 209–209. 4 indexed citations
20.
Scher, Howard I., Jessica Louw, Rachel Krupa, et al.. (2014). Characterization of Circulating Tumor Cells (Ctcs) of Metastatic Castration Resistant Prostate Cancer (Mcrpc) Patients in First, Second & Third Line Systemic Therapies. Annals of Oncology. 25. iv79–iv79. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin-Chao Wang Breakdown of academic impact, for papers by Maheshwari Ramineni Breakdown of academic impact, for papers by Anne Renolen Breakdown of academic impact, for papers by Nicolas Kiavué Breakdown of academic impact, for papers by Robert Konschak Breakdown of academic impact, for papers by Antonio Russo Breakdown of academic impact, for papers by Elisabeth Trapp Breakdown of academic impact, for papers by Daisy Dandan Wang Breakdown of academic impact, for papers by Lisa Flaum Breakdown of academic impact, for papers by Risa Oshitanai
Rankless by CCL
2026